IFRX Latest Headlines

Analysts Offer Insights on Healthcare Companies: Xoma (XOMA) and InflaRx (IFRX)

at www.tipranks.com (Wed, 31-Dec 8:10 AM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: InflaRx (IFRX) and Xoma (XOMA)

at www.tipranks.com (Wed, 31-Dec 8:00 AM)

Analysts Conflicted on These Healthcare Names: InflaRx (IFRX) and Globus Medical (GMED)

at www.tipranks.com (Tue, 30-Dec 10:50 AM)

InflaRx Reveals Phase 3 Post-Hoc Efficacy Signals for Vilobelimab in Pyoderma Gangrenosum After Trial Halt

at www.tipranks.com (Tue, 30-Dec 8:19 AM)

INF904 Shows Rapid Clinical Benefits in Phase 2a Trials for Hidradenitis Suppurativa and CSU, Reinforcing Best-in-Class Potential

Market Chameleon (Tue, 11-Nov 10:36 AM)

InflaRx Readies Topline Data Release for Phase 2a INF904 Trial—All Eyes on Upcoming November 10th Webcast

Market Chameleon (Mon, 10-Nov 9:54 AM)